Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017:2017:1796145.
doi: 10.1155/2017/1796145. Epub 2017 Aug 17.

Clinical Characteristics in Patients with Triple Negative Breast Cancer

Janet Yeh  1 , Jennifer Chun  1 , Shira Schwartz  1 , Annie Wang  2 , Elizabeth Kern  3 , Amber A Guth  1 , Deborah Axelrod  1 , Richard Shapiro  1 , Freya Schnabel  1
Affiliations

Clinical Characteristics in Patients with Triple Negative Breast Cancer

Janet Yeh et al. Int J Breast Cancer. 2017.

Abstract

Purpose: The purpose of this study was to compare and contrast the clinical characteristics of the triple negative breast cancer (TNBC) and non-TNBC patients, with a particular focus on genetic susceptibility and risk factors prior to diagnosis.

Methods: Our institutional database was queried for all patients diagnosed with invasive breast cancer between January 2010 and May 2016.

Results: Out of a total of 1964 patients, 190 (10%) patients had TNBC. The median age for both TNBC and non-TNBC was 59 years. There was a significantly higher proportion of African American and Asian patients with TNBC (p = 0.0003) compared to patients with non-TNBC. BRCA1 and BRCA2 were significantly associated with TNBC (p < 0.0001, p = 0.0007). A prior history of breast cancer was significantly associated with TNBC (p = 0.0003). There was no relationship observed between TNBC and a history of chemoprevention or patients who had a history of AH or LCIS.

Conclusions: We found that having Asian ancestry, a prior history of breast cancer, and a BRCA1 or BRCA2 mutation all appear to be positively associated with TNBC. In order to develop more effective treatments, better surveillance, and improved prevention strategies, it is necessary to improve our understanding of the population at risk for TNBC.

PubMed Disclaimer

References

    1. Carey L. A., Perou C. M., Livasy C. A., et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. The Journal of the American Medical Association. 2006;295(21):2492–2502. doi: 10.1001/jama.295.21.2492. - DOI - PubMed
    1. Nguyen P. L., Taghian A. G., Katz M. S., et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. Journal of Clinical Oncology. 2008;26(14):2373–2378. doi: 10.1200/jco.2007.14.4287. - DOI - PubMed
    1. Sørlie T. Molecular portraits of breast cancer: Tumour subtypes as distinct disease entities. European Journal of Cancer. 2004;40(18):2667–2675. doi: 10.1016/j.ejca.2004.08.021. - DOI - PubMed
    1. Sørlie T., Perou C. M., Tibshirani R. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proceedings of the National Academy of Sciences of the United States of America. 2001;98(19):10869–10874. doi: 10.1073/pnas.191367098. - DOI - PMC - PubMed
    1. Sørlie T., Tibshirani R., Parker J. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proceedings of the National Academy of Sciences of the United States of America. 2003;100:8418–8423. doi: 10.1073/pnas.0932692100. - DOI - PMC - PubMed

LinkOut - more resources